Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma.

Abstract:

BACKGROUND:CD44 is a transmembrane glycoprotein and is associated with cell-matrix and cell-cell interactions. CD44 expression was shown to be relevant to tumour progression in various types of human cancer. The objective of this study was to investigate the relationship between the expression levels of the standard form of CD44 (CD44s), and clinicopathological characteristics in a subset of colorectal carcinomas (CRC). PATIENTS AND METHODS:A total of 96 cases of CRC were retrieved from the archives at the Department of Pathology at King Abdulaziz University, Jeddah, KSA. Immunohistochemistry was performed using antibodies to CD44s. A cut-off of <10% of positive neoplastic cells was used to define low expression, 10-50% to define moderate expression and >50% to define extensive expression. Statistical tests were used to determine the association of CD44s with clinicopathological characteristics in a subset of colorectal carcinomas and survival. RESULTS:Immunostaining results showed that there was no association between C44 immunoexpression and age of patients, tumour grade, depth of invasion, vascular invasion, recurrence and survival. CD44s immunolabelling was found to have an association with nodal metastasis and to be an independent predictor of nodal metastasis. CONCLUSION:Loss of CD44s immunolabelling in CRC is an independent favourable predictor of regional lymph node metastasis. On the other hand, CD44s loss has no significant association with disease recurrence or survival. Extensive in vivo and in vitro molecular studies are required to elucidate the possible mechanistic association of CD44s with tumour initiation, progression, invasion and metastasis in primary CRC, and in nodal and distant metastases.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Al-Maghrabi J,Gomaa W,Buhmeida A,Al-Qahtani M,Al-Ahwal M

subject

Has Abstract

pub_date

2012-08-01 00:00:00

pages

3455-61

issue

8

eissn

0250-7005

issn

1791-7530

pii

32/8/3455

journal_volume

32

pub_type

杂志文章
  • Intermediate stage Hodgkin's disease: preliminary results on 210 patients treated with four ABVD chemotherapy cycles plus extended versus involved field radiotherapy.

    abstract:BACKGROUND:To improve long-term survival by reducing toxicity in intermediate stage Hodgkin's disease patients, we compared the effects of involved field (IF) versus extended field (EF) irradiation administered after four cycles of ABVD regimen. MATERIALS AND METHODS:Two hundred and ten Hodgkin's disease patients, at ...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Anselmo AP,Cavalieri E,Osti FM,Cantonetti M,De Sanctis V,Alfo M,Amadori S,Enrici RM

    更新日期:2004-11-01 00:00:00

  • Grading and therapy monitoring of astrocytomas with 1H-spectroscopy: preliminary study.

    abstract::We examined 11 patients (9 male and 2 female, age 41 +/- 13) presenting astrocytomas of different malignancy grade (WHO) with single voxel (PRESS) and double voxel (STABLE) spectroscopy techniques. The content of choline in the tumors was determined as a function of their grade of malignity and a significant correlati...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Speck O,Thiel T,Hennig J

    更新日期:1996-05-01 00:00:00

  • CEA as a prognostic factor in colorectal cancer.

    abstract::We have measured serum CEA levels in 207 patients with colorectal cancer. CEA sensitivity was related to tumor stage in tumors located in the right colon, but not in tumors located in the left colon or the rectum. CEA had prognostic value in patients with tumors located in the right colon (p < 0.001) but not in the le...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Filella X,Molina R,Piqué JM,Grau JJ,Garcia-Valdecasas JC,Biete A,Novell F,Astudillo E,Bordas JM,Campo E

    更新日期:1994-03-01 00:00:00

  • Decitabine, a DNA methyltransferase inhibitor, reduces P-glycoprotein mRNA and protein expressions and increases drug sensitivity in drug-resistant MOLT4 and Jurkat cell lines.

    abstract::Multidrug resistance (MDR) is a major clinical obstacle in the treatment of several cancers including hematological malignancies and solid tumors. The ATP-binding cassette transporter B1 (ABCB1) gene and its product, P-glycoprotein (P-gp), is one molecule that is involved in drug resistance. Here we report on the effe...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Onda K,Suzuki R,Tanaka S,Oga H,Oka K,Hirano T

    更新日期:2012-10-01 00:00:00

  • Competitive reverse transcriptase-PCR: an improved method for determination of c-erbB-2 gene expression.

    abstract::The aim of our study was to establish a simple method for routine analysis of c-erbB-2 gene expression in tumour samples. We constructed a plasmid for the in vitro synthesis of competitor RNA to be used as an internal exogenous control during the RT-PCR detection of c-erbB-2 expression. The competitor RNA harbors a 19...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Schneeberger C,Eder S,Speiser P,Zeillinger R

    更新日期:1996-03-01 00:00:00

  • GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysis.

    abstract:BACKGROUND:Understanding molecular abnormalities could potentially lead to novel investigational approaches in the molecular epidemiology of lung cancer. These might include the identification of patients at high risk for primary NSCLC and the surveillance of patients with known NSCLC who are being treated using lung-s...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Curigliano G,Ferretti G,Mandalà M,De Pas T,Calabrò MG,Solli P,Noberasc C,de Braud F

    更新日期:2001-09-01 00:00:00

  • Bevacizumab plus IFN-alpha-2a in First-line Treatment of Patients With Advanced or Metastatic Renal Cell Carcinoma: A Prospective German Non-interventional Study.

    abstract:BACKGROUND/AIM:The combination of bevacizumab (BEV) plus interferon alpha-2a (IFN) constitutes an option for first-line treatment of metastatic renal cell carcinoma. Real-world data from routine clinical practice are rare and were, therefore, collected during this non-interventional study (NIS). PATIENTS AND METHODS:A...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13188

    authors: Schultze-Seemann W,Schulz H,Tschechne B,Häckl M

    更新日期:2019-02-01 00:00:00

  • Impact of Small Molecules on β-Catenin and E-Cadherin Expression in HPV16-positive and -negative Squamous Cell Carcinomas.

    abstract:BACKGROUND:The validation of potential molecular targets in head and neck squamous cell carcinoma (SCC) is mandatory. β-Catenin and E-cadherin are crucial for cancer progression through epithelial-mesenchymal transition. We analyzed the effect of the tyrosine kinase inhibitors nilotinib, dasatinib, erlotinib and gefiti...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11636

    authors: Kramer B,Hock C,Schultz JD,Lammert A,Kuhlin B,Birk R,Hörmann K,Aderhold C

    更新日期:2017-06-01 00:00:00

  • Comparison of nuclear matrix protein 22 and bladder tumor antigen in urine of patients with bladder cancer.

    abstract::Recently, two new tumor markers for bladder cancer have been introduced: NMP22 test and BTA TRAK assay. This study was designed to evaluate the urinary values of these two proteins using quantitative enzyme immunoassays in well microplates. Urine samples from 47 healthy subjects, 26 with benign genitourinary disorders...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Abbate I,D'Introno A,Cardo G,Marano A,Addabbo L,Musci MD,Pagliarulo A,Correale M,Quaranta M

    更新日期:1998-09-01 00:00:00

  • Gemcitabine as a radiosensitizer in undifferentiated tumors.

    abstract:BACKGROUND:Gemcitabine (dFdC) may cause radiosensitization by specific interference with homologous recombination-mediated DNA double-strand break repair. The radiosensitizing effect of dFdC might be less in normal healthy tissue and more restricted to undifferentiated tumor cells, making it a tumor-selective radiosens...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kal HB,El Sharouni SY,Barten-van Rijbroek AD

    更新日期:2006-01-01 00:00:00

  • Response of T lymphocyte populations in prostate cancer patients undergoing radiotherapy: influence of neoajuvant total androgen suppression.

    abstract:BACKGROUND:This study sought to better define the immunological impact of combining neoadjuvant total androgen suppression (TAS) with radiotherapy (xRT) in treating prostate cancer. MATERIALS AND METHODS:Subjects selected (n = 37) were stage I-II prostate cancer patients meeting the eligibility requirements for RTOG p...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Johnke RM,Edwards JM,Kovacs CJ,Evans MJ,Daly BM,Karlsson UL,Lee TK,Allison RR,Arastu HH,Cariveau MJ,O'Brien KF

    更新日期:2005-07-01 00:00:00

  • Detection of p53 mutations in Hong Kong colorectal carcinomas by conventional PCR-SSCP analysis versus p53 yeast functional assays.

    abstract:BACKGROUND:Previous reports indicate that the p53 yeast functional assay is a highly sensitive method of detection of p53 mutations in clinical specimens. Our earlier report (1) showed a 35.4% p53 mutation frequency in Hong Kong colorectal carcinoma (CRC) patients, when conventional molecular screening techniques were ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Leung CS,Lung ML

    更新日期:1999-01-01 00:00:00

  • Prospective phase II study of post-surgical adjuvant chemo-immunotherapy using autologous dendritic cells and activated killer cells from tissue culture of tumor-draining lymph nodes in primary lung cancer patients.

    abstract:BACKGROUND:The efficacy and toxicity of adjuvant chemo-immunotherapy using dendritic cells and activated killer cells are not clear in post-surgical primary lung cancer patients. PATIENTS AND METHODS:Pathologically diagnosed N2 lung cancer patients were selected for postsurgical adjuvant chemo-immunotherapy. The activ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kimura H,Iizasa T,Ishikawa A,Shingyouji M,Yoshino M,Kimura M,Inada Y,Matsubayashi K

    更新日期:2008-03-01 00:00:00

  • Molecular Characterization of Second Primary Endometrial Cancer.

    abstract:BACKGROUND/AIM:The objective of this study was to determine the molecular and clinicopathological features, as well as the prognosis of patients with endometrial cancer (EC) having prior malignancy (second primary EC: SPEC) compared with those without a history of prior malignancy (first primary EC: FPEC). MATERIALS A...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14370

    authors: Haraga J,Nakamura K,Haruma T,Nyuya A,Nagasaka T,Masuyama H

    更新日期:2020-07-01 00:00:00

  • Urinary cyclic GMP after treatment of gynecological cancer. A prognostic marker of clinical outcome.

    abstract:BACKGROUND:The search for biological markers to predict malignant disease and its recurrence, or to monitor the effectiveness of treatment is a continuous process in medicine. Several years ago, urinary excretion of cGMP in urine was found to be a sensitive predictor in the follow-up of ovarian cancer and of monitoring...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Orbo A,Hanevik M,Jaeger R,Van Heusden S,Sager G

    更新日期:2007-07-01 00:00:00

  • Recurrent Leiomyosarcoma of the Small Bowel: A Case Series.

    abstract:BACKGROUND/AIM:Leiomyosarcoma is an extremely rare, small bowel neoplasm (2% of all gastrointestinal tumours). Early diagnosis is challenging due to the slow growth of the cancer. The biological behaviour of this group of tumours is aggressive, and the first-line treatment is surgical resection. PATIENTS AND METHODS:T...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14420

    authors: Ferrari C,DI Domenico S,Mascherini M,Santoliquido M,Mastracci L,DE Cian F

    更新日期:2020-07-01 00:00:00

  • Relapse of endometrial carcinoma: follow-up of 272 patients with relapse.

    abstract::A total of 2090 patients with endometrial carcinoma were followed-up for at least five years. The treatment modalities, as well as the results of treatment, regarding 272 patients with disease relapse are presented. The results are not encouraging. We found no statistically significant difference regarding overall sur...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lindahl B,Ranstam J,Willén R

    更新日期:2012-08-01 00:00:00

  • NF-kappaB-independent induction of endothelial cell apoptosis by the vascular disrupting agent DMXAA.

    abstract:BACKGROUND:DMXAA (5,6-dimethylxanthenone-4-acetic acid; AS1404), a vascular disrupting agent currently in clinical trials, induces tumour endothelial cell apoptosis in vivo in mice and in cancer patients. DMXAA activates NF-kappaB in many different cell types. In this study, whether DMXAA-induced endothelial cell apopt...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Woon ST,Hung SS,Wu DC,Schooltink MA,Sutherland R,Baguley BC,Chen Q,Chamley LW,Ching LM

    更新日期:2007-01-01 00:00:00

  • PTHrP regulates angiogenesis and bone resorption via VEGF expression.

    abstract:BACKGROUND:Parathyroid hormone-related protein (PTHrP) is a key regulator of osteolytic metastasis of breast cancer (BC) cells, but its targets and mechanisms of action are not fully understood. This study investigated whether/how PTHrP (1-34) signaling regulates expression of vascular endothelial growth factor (VEGF) ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Isowa S,Shimo T,Ibaragi S,Kurio N,Okui T,Matsubara K,Hassan NM,Kishimoto K,Sasaki A

    更新日期:2010-07-01 00:00:00

  • Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer.

    abstract::Ovarian cancer is the most lethal malignancy among gynaecological cancers. Although many anticancer agents have been developed for the treatment of ovarian cancer, it continues to have an extremely poor prognosis. Heparin-binding epidermal growth factor-like grown factor (HB-EGF) has been reported to be a rational the...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11779

    authors: Miyata K,Yotsumoto F,Fukagawa S,Kiyoshima C,Ouk NS,Urushiyama D,Ito T,Katsuda T,Kurakazu M,Araki R,Sanui A,Miyahara D,Murata M,Shirota K,Yagi H,Takono T,Kato K,Yaegashi N,Akazawa K,Kuroki M,Yasunaga S,Miyamoto S

    更新日期:2017-07-01 00:00:00

  • Bortezomib Causes ER Stress-related Death of Acute Promyelocytic Leukemia Cells Through Excessive Accumulation of PML-RARA.

    abstract:BACKGROUND/AIM:The success of proteasome inhibitors in therapy of multiple myeloma has led to their use for other malignancies. For the proteasome inhibitor bortezomib, combination therapies with histone deacetylase inhibitors, which up-regulate ubiquitin-proteasome system (UPS)-related enzymes, produce a beneficial ef...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Takenokuchi M,Miyamoto K,Saigo K,Taniguchi T

    更新日期:2015-06-01 00:00:00

  • Proteomic analysis to dissect mitoxantrone resistance-associated proteins in a squamous lung carcinoma.

    abstract:BACKGROUND:Mitoxantrone resistance has been related to the expression of a drug efflux pump breast cancer resistance pump (BCRP) but little is known of the intracellular protein changes. In this work, differential protein expression in a squamous lung carcinoma cell line, DLKP, and its mitoxantrone-resistant variant (D...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Murphy L,Clynes M,Keenan J

    更新日期:2007-05-01 00:00:00

  • Whole-transcriptome analysis reveals established and novel associations with TMPRSS2:ERG fusion in prostate cancer.

    abstract:BACKGROUND/AIM:Shortcomings of current methods of prostate cancer detection call for improved biomarkers. The transmembrane protease, serine 2:ets-related gene (TMPRSS2:ERG) gene fusion leads to the overexpression of ERG, an E-twenty six (ETS) family transcription factor, and is the most prevalent genetic lesion in pro...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Chow A,Amemiya Y,Sugar L,Nam R,Seth A

    更新日期:2012-09-01 00:00:00

  • Molecular species of the antitumor and antiviral fraction from pine cone extract.

    abstract::The most active fraction (Fr. VI) of antitumor and antiviral pine cone extract was subjected to chemical structure analysis. IR, UV, and ESR spectroscopies, in addition to chromatographic analysis on cellulose-TLC plates, reveal that the major component of Fr. VI includes structures belonging to the lignin family. A c...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Sakagami H,Oh-Hara T,Kaiya T,Kawazoe Y,Nonoyama M,Konno K

    更新日期:1989-11-01 00:00:00

  • Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer risk.

    abstract::The relationship between the composition of breast cyst fluid (BCF), the menstrual status and in addition some endocrine events in the history of patients (n = 131) with gross cystic breast disease was investigated. The dehydroepiandrosterone (DHA) levels in type II (K+/Na+ < 1) cysts of the follicular group were sign...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Budai B,Számel I,Sulyok Z,Németh M,Bak M,Kralovánszky J,Ottó S,Besznyák I,Purohit A,Parish DC,Reed MJ

    更新日期:2000-09-01 00:00:00

  • Clinical and Prognostic Significance of Neoplastic Spindle Cells in Gallbladder Cancer.

    abstract:BACKGROUND/AIM:Neoplastic spindle cells (NSCs) are believed to play a role in cancer invasion and metastasis, as well as in poor prognosis. The clinicopathological characteristics and prognostic relevance of NSCs was investigated in gallbladder cancer. MATERIALS AND METHODS:Specimens were obtained from 62 patients wit...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13634

    authors: Midorikawa R,Hisaka T,Sakai H,Nomura Y,Goto Y,Sato T,Kawahara R,Ishikawa H,Fujita F,Yasunaga M,Tanigawa M,Naito Y,Akiba J,Yano H,Tanaka H,Akagi Y,Okuda K

    更新日期:2019-08-01 00:00:00

  • Metallothionein expression prevents apoptosis. II: Evaluation of the role of metallothionein expression on the chemotherapy-induced apoptosis during the treatment of acute leukemia.

    abstract::Metallothioneins (MT) are low molecular weight cysteine-rich proteins, present in a wide variety of eukaryotes. Although their physiological function is not entirely understood, recently it was found that in vitro human MTs (hMTs) expression prevents apoptosis. In the present study, the apoptosis preventing effect of ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tsangaris GT,Vamvoukakis J,Politis I,Kattamis AC,Tzortzatou-Stathopoulou F

    更新日期:2000-11-01 00:00:00

  • Radiation-induced DNA damage and its repair in lymphocytes of patients with head and neck cancer and healthy donors.

    abstract:BACKGROUND:DNA repair capacity may be an important factor in determining both individual susceptibility to cancer and the response to cancer therapy. The aim of this work was to compare DNA damage and the repair process in cells originating from healthy donors and cancer patients. MATERIALS AND METHODS:Using the micro...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Palyvoda O,Mukalov I,Polanska J,Wygoda A,Drobot L,Widel M,Rzeszowska-Wolny J

    更新日期:2002-05-01 00:00:00

  • Update on Surgical Management of Small Bowel Neuroendocrine Tumors.

    abstract::The widespread use of endoscopy and imaging in combination with the continuous update of the staging systems for neuroendocrine tumors has led to an increase in the incidence of small intestinal neuroendocrine tumors (si-NENs) globally. Despite high survival rates, severe complications may occur even in early stages d...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:10.21873/anticanres.12349

    authors: Moris D,Ntanasis-Stathopoulos I,Tsilimigras DI,Vagios S,Karamitros A,Karaolanis G,Griniatsos J,Papalampros A,Papaconstantinou I,Glantzounis GK,Spartalis E,Blazer DG 3rd,Felekouras E

    更新日期:2018-03-01 00:00:00

  • A review of dose-dense temozolomide alone and in combination with bevacizumab in patients with first relapse of glioblastoma.

    abstract::Treatment of patients with glioblastoma improved dramatically when concomitant and adjuvant temozolomide was added to external radiation therapy. The addition of this new treatment schedule as well as the improvements in individually-tailored radiation treatment, has resulted in a larger proportion of patients being f...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Johansson F,Ekman S,Blomquist E,Henriksson R,Bergström S,Bergqvist M

    更新日期:2012-09-01 00:00:00